24th Aug 2015 14:51
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Spire Healthcare Group plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights:
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:
An event changing the breakdown of voting rights: ( )
Other (please specify):
Change in beneficial ownership YES
3. Full name of person(s) subject to the notification obligation:
Mediclinic international limited
4. Full name of shareholder(s) (if different from 3.):
REMGRO JERSEY LIMITED
5. Date of the transaction (and date on which the threshold is crossed or reached if different): 24 August 2015
6. Date on which issuer notified: 24 August 2015
7. Threshold(s) that is/are crossed or reached:
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
ORDINARY ISIN: GB00BNLPYF73 | 119,923,335 | 119,923,335 | 119,923,335 | 29.9% | |||
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Expiration Date | Exercise/Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to | % of voting rights |
Nominal | Delta | ||||
Total (A+B+C)
| |
Number of voting rights | % of voting rights |
119,923,335 | 29.9% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
1. Mediclinic International Limited (ultimate parent): indirect holding of 29.9% of voting rights in issuer.
2. Mediclinic Investments (Pty) Ltd (wholly owned subsidiary of Mediclinic International Limited): indirect holding of 29.9% of voting rights in issuer.
3. Business Venture Investments No 1871 (Pty) Ltd (wholly owned subsidiary of Mediclinic Investments (Pty) Ltd): indirect holding of 29.9% of voting rights in issuer.
4. Remgro Jersey Limited (wholly owned subsidiary of Business Venture Investments No 1871 (Pty) Ltd): direct holding of 29.9% of voting rights in issuer.
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information:
The change in beneficial ownership resulted in the acquisition by Mediclinic International Limited, through a wholly owned subsidiary Mediclinic Investments (Pty) Ltd of all the issued shares in Business Venture Investments No 1871 (Pty) Ltd, which in turn owns all the issued shares in Remgro Jersey Limited which company is a 29.9% shareholder of Spire Healthcare Group Plc.
14. Contact name:
Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc
15. Contact telephone number:
+ 44 (0)20 7427 9092
Related Shares:
Spire Healthcare